Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
(Q1)Mar 30, 2025 | (FY)Dec 29, 2024 | (Q4)Dec 29, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Oct 1, 2023 | (Q2)Jul 2, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.65%297.41M | 4.29%1.32B | 3.04%335.01M | 10.70%344.27M | 5.17%346.64M | -2.05%289.74M | -2.81%1.26B | -3.11%325.12M | -5.11%311.01M | 329.58M |
Operating revenue | 2.65%297.41M | 4.29%1.32B | 3.04%335.01M | 10.70%344.27M | 5.17%346.64M | -2.05%289.74M | -2.81%1.26B | -3.11%325.12M | -5.11%311.01M | --329.58M |
Cost of revenue | 3.97%186.45M | 1.50%832.71M | 5.32%212.71M | 7.92%216.65M | 2.86%224.02M | -10.29%179.34M | -4.62%820.43M | -12.23%201.97M | -8.32%200.75M | 217.8M |
Gross profit | 0.51%110.96M | 9.49%482.95M | -0.69%122.31M | 15.75%127.63M | 9.69%122.61M | 15.16%110.41M | 0.76%441.07M | 16.79%123.15M | 1.35%110.26M | 111.79M |
Operating expense | 2.07%87.74M | 2.80%348.54M | 5.31%92.67M | 7.79%85.45M | -1.24%84.46M | -0.34%85.96M | 4.58%339.05M | 5.42%88M | -1.95%79.27M | 85.52M |
Selling and administrative expenses | 2.07%87.74M | 2.80%348.54M | 5.31%92.67M | 7.79%85.45M | -1.24%84.46M | -0.34%85.96M | 4.58%339.05M | 5.42%88M | -1.95%79.27M | --85.52M |
Operating profit | -4.99%23.23M | 31.74%134.41M | -15.70%29.63M | 36.11%42.18M | 45.26%38.15M | 154.14%24.45M | -10.15%102.02M | 60.04%35.15M | 10.91%30.99M | 26.26M |
Net non-operating interest income expense | 31.26%-4.42M | 27.00%-23.21M | 28.13%-4.89M | 29.92%-5.72M | 25.79%-6.17M | 24.48%-6.42M | -6.21%-31.79M | 16.47%-6.8M | -5.37%-8.16M | -8.32M |
Non-operating interest expense | -31.26%4.42M | -27.00%23.21M | -28.13%4.89M | -29.92%5.72M | -25.79%6.17M | -24.48%6.42M | 6.21%31.79M | -16.47%6.8M | 5.37%8.16M | --8.32M |
Other net income (expense) | -274.49%-1.7M | 135.77%2.35M | 284.08%2.59M | 94.32%-381K | -126.23%-832K | 159.44%976K | 84.22%-6.58M | 96.34%-1.41M | -35,173.68%-6.7M | 3.17M |
Special income (charges) | ---- | --0 | --0 | --0 | --0 | --0 | 106.56%2.5M | --0 | --0 | --2.64M |
-Less:Restructuring and merger&acquisition | ---- | --0 | ---- | ---- | ---- | --0 | -227.33%-2.5M | ---- | ---- | ---- |
-Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non- operating income (expenses) | -274.49%-1.7M | 125.91%2.35M | 284.08%2.59M | 94.32%-381K | -257.58%-832K | 165.07%976K | -155.66%-9.08M | 24.52%-1.41M | -5,304.84%-6.7M | --528K |
Income before tax | -9.95%17.11M | 78.39%113.55M | 1.45%27.34M | 123.78%36.07M | 47.49%31.15M | 3,698.30%19M | 51.86%63.65M | 209.55%26.94M | -20.08%16.12M | 21.12M |
Income tax | -14.79%4.11M | 39.04%26.61M | -24.62%5.57M | 22.26%7.63M | 61.40%8.59M | 2,491.40%4.82M | -14.40%19.14M | 35,085.71%7.39M | 2.21%6.24M | 5.32M |
Net income | -8.30%13M | 95.31%86.95M | 11.31%21.77M | 187.91%28.44M | 42.80%22.56M | 2,085.85%14.18M | 127.59%44.52M | 179.44%19.56M | -29.76%9.88M | 15.8M |
Net income continuous Operations | -8.30%13M | 95.31%86.95M | 11.31%21.77M | 187.91%28.44M | 42.80%22.56M | 2,085.85%14.18M | 127.59%44.52M | 179.44%19.56M | -29.76%9.88M | --15.8M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -8.30%13M | 95.31%86.95M | 11.31%21.77M | 187.91%28.44M | 42.80%22.56M | 2,085.85%14.18M | 127.59%44.52M | 179.44%19.56M | -29.76%9.88M | 15.8M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | -16.67%500K | -72.53%75K | 1.71%119K | -42.33%109K | 1,566.67%150K | 100.00%600K | 165.63%273K | -52.44%117K | 189K | |
Net income attributable to common stockholders | -8.30%13M | 96.84%86.45M | 12.49%21.69M | 190.15%28.32M | 43.83%22.45M | 2,061.13%14.18M | 128.02%43.92M | 179.68%19.28M | -29.36%9.76M | 15.61M |
Basic earnings per share | -8.33%0.22 | 93.51%1.49 | 8.82%0.37 | 188.24%0.49 | 44.44%0.39 | 2,500.00%0.24 | 133.33%0.77 | 180.95%0.34 | -29.17%0.17 | 0.27 |
Diluted earnings per share | -8.33%0.22 | 94.74%1.48 | 12.12%0.37 | 182.35%0.48 | 40.74%0.38 | 2,500.00%0.24 | 130.30%0.76 | 178.57%0.33 | -29.17%0.17 | 0.27 |
Dividend per share | 0.00%0.01 | 0.00%0.04 | 0.00%0.01 | 0.00%0.01 | 0.00%0.01 | 0.00%0.01 | 0.00%0.04 | 0.00%0.01 | 0.00%0.01 | 0.01 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |